SCHEMBL17596259

SCHEMBL17596259

CC1Cn2c(nnc2-c2ccc(C(F)(F)F)cc2)CN1C(=O)c1cccc(Cl)c1Cl

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17596258 1.00 P2RX7 (0.81) P2RX7
SCHEMBL17596577 0.92 P2RX7 (0.86) P2RX7
SCHEMBL17596574 0.92 P2RX7 (0.86) P2RX7
SCHEMBL17595591 0.90 P2RX7 (1.00) P2RX7
SCHEMBL17595626 0.90 P2RX7 (1.00) P2RX7
SCHEMBL17596271 0.90 P2RX7 (1.00) P2RX7
SCHEMBL20099678 0.89 P2RX7 (0.86) P2RX7
SCHEMBL17596480 0.88 P2RX7 (1.00) P2RX7
SCHEMBL17596191 0.88 P2RX7 (1.00) P2RX7
SCHEMBL17596192 0.88 P2RX7 (1.00) P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191488-A1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES Janssen Pharmaceutica, N.V. (BE) 2017-07-19 EP claimed
WO-2016039983-A1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES JANSSEN PHARMACEUTICA NV (BE) 2016-03-17 WO claimed
EP-3191488-B1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES JANSSEN PHARMACEUTICA NV (BE) 2019-08-14 EP disclosed
EP-3191488-B1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES JANSSEN PHARMACEUTICA NV (BE) 2019-08-14 EP disclosed
EP-3191488-A1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES Janssen Pharmaceutica, N.V. (BE) 2017-07-19 EP disclosed
WO-2016039983-A1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES JANSSEN PHARMACEUTICA NV (BE) 2016-03-17 WO disclosed